Abstract
Nineteen patients resistant to an adriamycin-containing regimen were treated with 4 days of tericin B and the same adriamycin-containing chemotherapy regimen that had been given without amphotericin B. Of the 14 evaluable patients (11 with breast carcinoma and three with sarcoma), one patient with breast carcinoma achieved a partial remission and a second patient with breast carcinoma remained stable. All other patients developed progressive disease. Both hematologic and nonhematologic toxicity were significantly increased when amphotericin B was added to chemotherapy.
Original language | English (US) |
---|---|
Pages (from-to) | 1565-1567 |
Number of pages | 3 |
Journal | Cancer Treatment Reports |
Volume | 62 |
Issue number | 10 |
State | Published - Dec 1 1978 |
Externally published | Yes |
ASJC Scopus subject areas
- Oncology
- Cancer Research